Tag: Silk Road

TCAR: First patient enrolled in ROADSTER 3 post-approval study

Silk Road Medical has announced enrollment of the first patient in ROADSTER 3, which the company claims is the the first prospective, multicenter, single-arm...

Silk Road to evaluate TCAR in standard surgical risk patients with...

Silk Road Medical today announced a post-market study to evaluate the transcarotid artery revascularization (TCAR) system in the treatment of standard surgical risk patients...

Expanded Medicare coverage for TCAR in standard surgical risk patients...

Silk Road Medical today announced that the Centers for Medicare and Medicaid Services (CMS), through collaboration with the Society of Vascular Surgery's Patient Safety...

FDA approves expanded indications for TCAR’s Enroute stent

The Food and Drug Administration (FDA) approved expanded indications for the Enroute stent system—part of the transcarotid artery revascularization (TCAR) procedure—to include patients at...